Anti-Human PCSK9 Recombinant Antibody(Bococizumab)

Product Information

Catalog Number	YR1327
Product Name	Anti-Human PCSK9 Recombinant Antibody(Bococizumab)
Molecular Name	Bococizumab
Alias	Anti-PCSK9 Recombinant Antibody, Research Grade Bococizumab
CAS Number	1407495-02-6
Target	PCSK9[Homo sapiens]
Isotype	IgG2 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FCM, IP, ELISA, Neut, FuncS
Buffer	PBS, pH7.5
Background	Bococizumab (USAN, development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price